Polysulfide hyaluronan GlycoMira-1111 (GM-1111) was found to inhibit interactions between RAGE and CML, HMGB1, and S100B and exhibited anti-inflammatory activity [103,104]. Here, S100B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.